Clinical Trials
13 trialsNCT05880082 2025-08-24
PPIO-004-EC001
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Phase 2 Completed
NCT02776163 2024-07-30
Postoperative Concurrent Chemoradiotherapy in Treating Patients With High-Risk Salivary Gland Carcinomas
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2 Completed
NCT02350517 2023-02-16
Endostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal Cancer
Sun Yat-sen University
Phase 2 Completed
NCT04834206 2022-05-10
Nedaplatin in Treatment for Nasopharyngeal Carcinoma
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Phase 2 Completed
NCT02964455 2020-05-15
Study of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
Sun Yat-sen University
Phase 1 Completed
NCT01040312 2019-05-23
An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid Tumors
Daiichi Sankyo
Completed
NCT02088515 2017-03-03
Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 4 Completed
NCT02429622 2017-01-18
Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy for Locally Advanced Esophageal Carcinoma
ChineseAMS
Phase 1/2 Completed
NCT01540136 2016-10-28
Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3 Completed
NCT02861690 2016-08-10
Liposomal Paclitaxel Combined Nedaplatin in Treatment of Advanced or Recurrent Esophageal Carcinoma
Sun Yat-sen University
Phase 2 Completed
NCT01712919 2014-03-24
Chemoradiation Plus Weekly c225 Against Locoregionally Advanced Nasopharyngeal Carcinoma (NPC)
Jiangsu Cancer Institute & Hospital
Phase 1/2 Completed
NCT01175460 2012-03-06
S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal Cancer
Zhejiang Cancer Hospital
Phase 1 Completed
NCT00197444 2009-02-20
Low-Dose Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum)/5-FU Combined With Radiation for Esophageal Cancer
Hamamatsu University
Phase 2 Completed